Research Progress of 177Lu-DOTATATE in the Treatment of Neuroendocrine Tumor Patients with Environmental Radiation Safety
Neuroendocrine tumors (NENs) are rare tumors arising from neuroendocrine cells distributed throughout the body. 177Lu-DOTATATE has been shown to significantly prolong the progression-free survival of patients, and has been widely used abroad. There are many studies on the radiation safety of 177Lu-D...
Main Author: | MA Guangyu;BA Jiantao;PENG Cheng;CHEN Yingmao |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Board of Journal of Isotopes
2022-04-01
|
Series: | Journal of Isotopes |
Subjects: | |
Online Access: | http://www.tws.org.cn/CN/10.7538/tws.2021.youxian.047 |
Similar Items
-
Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE
by: N.R. Hidayati, et al.
Published: (2019-12-01) -
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
by: Madhav Prasad Yadav, et al.
Published: (2019-02-01) -
Efficacy and safety of 177Lu-DOTATATE targeted therapy in advanced/metastatic pulmonary neuroendocrine tumors: A systematic review and meta-analysis
by: Jiao Ma, et al.
Published: (2022-11-01) -
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
by: Mattias Sandström, et al.
Published: (2020-12-01) -
<sup>177</sup>Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
by: Alberto Bongiovanni, et al.
Published: (2022-12-01)